Table 2: Detailed Demographics, Clinical Data and Distribution of Risk Scores.
1: risk scores; Pt: patient; Dx: diagnosis; M: male, F: female; Hb: Hemoglobin; CRP: C-reactive protein; Alb: albumin; PCDAI: pediatric Crohn’s disease activity index; PUCAI: Pediatric ulcerative colitis activity index; Ps: psychosocial; Phys: physical; M: male; F: female; CD: Crohn’s disease; UC: Ulcerative Colitis; L, E: Paris classification categories for disease location in CD and UC, respectively, see Table 1.
Pt # | Demographics | Dx | Paris Classif. | Anemia | Disease Activity | PedsQL 4.0 Scores |
Patient-reported | Parent-reported |
Age at Dx | Age at Enrollment | M or F | Hb (g/dl) | CRP (mg/dL) | Alb (g/dL) | PCD AI | PUC AI | Ps | Phys | Total | Ps | Phys | Total |
A Patients in Remission with Normal Hemoglobin (n=10) |
1 | 7 | 14 | M | CD | L1 | 13.1 | 0.2 | 3.3 | 7 | | 71 | 721 | 71 | 81 | 97 | 87 |
2 | 13 | 16 | F | CD | L3 | 12.4 | 0.0 | 3.6 | 5 | | 95 | 100 | 97 | 100 | 94 | 98 |
3 | 16 | 17 | F | CD | L3/4a | 13.4 | 0.5 | 3.7 | 5.0 | | 68 | 88 | 75 | 75 | 84 | 78 |
4 | 14 | 15 | F | CD | L3 | 12.6 | 0.0 | 3.7 | 0.0 | | 100 | 91 | 97 | 92 | 78 | 87 |
5 | 11 | 14 | M | CD | L3 | 13.9 | 0.0 | 4.2 | 0.0 | | 97 | 94 | 96 | 93 | 94 | 93 |
6 | 14 | 15 | M | CD | L2 | 14.6 | 0.0 | 3.5 | 5.0 | | 90 | 94 | 91 | 85 | 94 | 88 |
7 | 13 | 15 | F | CD | L3/4a | 12.7 | 1.0 | 3.6 | 5.0 | | 93 | 91 | 92 | 85 | 88 | 86 |
8 | 13 | 15 | M | CD | L3/4b | 13.3 | 0.0 | 3.6 | 1.3 | | 82 | 97 | 87 | 83 | 100 | 89 |
9 | 13 | 15 | M | CD | L3 | 13.3 | 0.0 | 4.2 | 0.0 | | 67 | 100 | 78 | 75 | 91 | 80 |
10 | 13 | 16 | M | CD | L3/4a | 13.4 | 0.0 | 4.0 | 0.0 | | 88 | 97 | 91 | 87 | 100 | 91 |
B Patients in Remission with Anemia (n=8) |
1 | 9 | 15 | M | CD | L2 | 12.9 | 0.0 | 4.0 | 10 | | 77 | 84 | 79 | 581 | 81 | 611 |
2 | 11 | 13 | F | UC | E2 | 11.9 | 0.0 | 3.2 | | 5 | 601 | 721 | 641 | 331 | 441 | 371 |
3 | 13 | 17 | F | CD | L3 | 10.0 | 0.0 | 3.2 | 7.5 | | 381 | 631 | 471 | 80 | 94 | 85 |
4 | 14 | 16 | M | UC | E4 | 8.9 | 0.0 | 3.4 | | 0 | 85 | 84 | 85 | 80 | 84 | 82 |
5 | 8 | 9 | M | UC | E2 | 8.1 | 0.0 | 4.0 | | 0 | 97 | 100 | 98 | 87 | 94 | 89 |
6 | 13 | 13 | M | CD | L3 | 12.0 | 0.0 | 3.7 | 10.0 | | 581 | 591 | 591 | 631 | 69 | 651 |
7 | 17 | 17 | F | CD | L3 | 11.8 | 0.0 | 3.2 | 5.0 | | 67 | 381 | 571 | 501 | 501 | 501 |
8 | 9 | 14 | M | CD | L3 | 12.8 | 1.0 | 3.5 | 0.0 | | 88 | 84 | 87 | 631 | 591 | 621 |
C Patients with Active Disease and Normal Hemoglobin (n=3) |
1 | 6 | 7 | F | CD | L3/4a | 11.7 | 1.0 | 2.5 | 35 | | 67 | 691 | 671 | 601 | 631 | 611 |
2 | 5 | 7 | M | CD | L2 | 11.5 | 1.0 | 3.4 | 32.5 | | 631 | 501 | 591 | 451 | 66 | 521 |
3 | 12 | 14 | M | CD | L3 | 13.6 | 1.2 | 4.3 | 0.0 | | 72 | 78 | 74 | 77 | 91 | 82 |
D Patients with Active Disease and Anemia (n=9) |
1 | 9 | 14 | M | CD | L2 | 10.5 | 0.0 | 3.6 | 18 | | 73 | 691 | 72 | 631 | 631 | 631 |
2 | 12 | 12 | F | CD | L1/4b | 11.9 | 2.0 | 2.7 | 10.0 | | 92 | 84 | 89 | 78 | 84 | 80 |
3 | 7 | 8 | F | CD | L3/4a | 10.8 | 0.0 | 3.2 | 40.0 | | 85 | 721 | 80 | 85 | 69 | 79 |
4 | 9 | 11 | M | CD | L2/4a | 12.1 | 3.0 | 2.6 | 27.5 | | 90 | 661 | 82 | 87 | 591 | 77 |
5 | 5 | 6 | M | CD | L3/4ab | 9.7 | 1.0 | 2.7 | 32.5 | | 67 | 691 | 671 | 77 | 66 | 73 |
6 | 10 | 12 | F | CD | L4b | 11.3 | 1.0 | 2.4 | 40.0 | | 87 | 81 | 85 | 621 | 531 | 591 |
7 | 11 | 11 | M | CD | L3 | 10.9 | 0.0 | 3.5 | 12.5 | | 581 | 661 | 611 | 501 | 631 | 541 |
8 | 9 | 16 | M | CD | L3/4a | 12.9 | 1.0 | 3.2 | 12.5 | | 82 | 100 | 88 | 82 | 97 | 87 |
9 | 10 | 10 | F | CD | L2 | 9.3 | 1.0 | 3.7 | 12.5 | | 98 | 100 | 99 | 87 | 88 | 87 |